Syrris Inc. has announced that it have been appointed distributors of the Lara Controlled Lab Reactor (CLR) and the Coflux reaction monitoring and calorimetry system in North America.
According to Syrris, Lara CLR is a flexible and modular chemical reactor that is both affordable and highly automated.
It can accommodate variable vessel size, ranging from 100ml to 5 litres, and it incorporates easy-to-use software which allows extensive reaction design and full data logging.
The Coflux (Constant Flux) system uses the Lara CLR software to gather real-time reaction data such as power and enthalpy change.
With minimal calibration, accurate temperature measurements are afforded through a thermal jacket comprising of numerous coolant tubes surrounding the reaction vessel.
Making the announcement, Richard Gray, Commercial Director said, “We have experienced great success with the Lara CLR and Coflux products and our expanding client base reaches across US, including major pharma companies such as GSK and Pfizer.”
He continued “this new appointment by Radleys ensures that customers in North America will receive the very best sales and technical support”.
Mark Radley, Managing Director of Radleys commented, “We’re confident Lara will offer significant benefits to customers in North America.”
“Syrris worked closely with us on the design and development of both Lara and Coflux, and so have great knowledge of these products and are in the ideal position to service the US market.”
Syrris will be exhibiting Lara and Coflux at the forthcoming Cambridge Healthcare Institute Process R&D Summit in Philadelphia from 24th-26th October.